Peter Boström - UTU Research Portal - UTU Research Portal

Go to Header Go to Navigation Go to Content Go to Footer

Peter Boström

- Professor,
Surgery (Department of Clinical Medicine)

peter.bostrom@utu.fi

: https://orcid.org/0000-0003-3647-0015

Go to first page

Go to previous page

21 of 24

Go to next page

Go to last page

Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies (2016)
- PLoS ONE
Alinezhad S, Väänänen RM, Mattsson J, Li YF, Tallgren T, Ochoa NT, Bjartell A, Åkerfelt M, Taimen P, Boström PJ, Pettersson K, Nees M
Virtsarakkosyövän hoidossa valoa tunnelin päässä (2016)
- Lääkärilehti
Boström PJ
Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates (2015)
- BMC Urology
Vaananen RM, Ochoa NT, Bostrom PJ, Taimen P, Pettersson K
Differential predictive roles of A- and B-type nuclear lamins in prostate cancer progression (2015)
- PLoS ONE
Saarinen I, Mirtti T, Seikkula H, Boström PJ, Taimen P
Diffusion-weighted imaging of prostate cancer: effect of b-value distribution on repeatability and cancer characterization (2015)
- Magnetic Resonance Imaging
Merisaari H, Toivonen J, Pesola M, Taimen P, Boström PJ, Pahikkala T, Aronen HJ, Jambor I
Erectile dysfunction cannot be used in primary screening of pre-diabetes (2015)
- Diabetes Research and Clinical Practice
Ettala OO, Korhonen PE, Syvanen KT, Kaipia AJ, Vahlberg TJ, Aarnio PT, Bostrom PJ
Eturauhasen sairaudet – Ennaltaehkäisy, tutkimukset ja hoito (2015) Boström Peter
Evaluation of different mathematical models for diffusion-weighted imaging of normal prostate and prostate cancer using high b-values: A repeatability study (2015)
- Magnetic Resonance in Medicine
Jambor Ivan, Merisaari Harri, Taimen Pekka, Boström Peter, Minn Heikki, Pesola Marko, Aronen Hannu Juhani
Genomic Predictors of Outcome in Prostate Cancer (2015)
- European Urology
Boström PJ, Bjartell AS, Catto JW, Eggener SE, Lilja H, Loeb S, Schalken J, Schlomm T, Cooperberg MR
Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly Bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: Prospective randomised finnbladder-4 study (2015)
- European Urology
Järvinen R., Marttila T., Kaasinen E., Rintala E., Aaltomaa S., Kallio J., Liukkonen T., Puolakka V., Seppänen M., Tuhkanen K., Vaarala M., Viitanen J., Boström P.; FinnBladder Group